DMRA earnings: a negative outcome, -7.4%

On November 8, 2022, Damora Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.4% in the window around the event. It had already run +11.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.